32 related articles for article (PubMed ID: 27354292)
1. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
Youland RS; Kitange GJ; Peterson TE; Pafundi DH; Ramiscal JA; Pokorny JL; Giannini C; Laack NN; Parney IF; Lowe VJ; Brinkmann DH; Sarkaria JN
J Neurooncol; 2013 Jan; 111(1):11-8. PubMed ID: 23086431
[TBL] [Abstract][Full Text] [Related]
2. 6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses.
Pretze M; Wängler C; Wängler B
Biomed Res Int; 2014; 2014():674063. PubMed ID: 24987698
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of
Masselli G; Casciani E; De Angelis C; Sollaku S; Gualdi G
Am J Nucl Med Mol Imaging; 2021; 11(2):64-76. PubMed ID: 34079636
[TBL] [Abstract][Full Text] [Related]
4. Could
Piccardo A; Treglia G
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):247-249. PubMed ID: 29181566
[No Abstract] [Full Text] [Related]
5. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
[TBL] [Abstract][Full Text] [Related]
6. In Reply to the Letter to the Editor Regarding "
Cicone F; Langen KJ; Minniti G
World Neurosurg; 2021 Jun; 150():255. PubMed ID: 34098660
[No Abstract] [Full Text] [Related]
7. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor Regarding "
Filippi L; Bagni O; Spinelli GP
World Neurosurg; 2021 Jun; 150():253-254. PubMed ID: 34098659
[No Abstract] [Full Text] [Related]
9. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
[TBL] [Abstract][Full Text] [Related]
10. (18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports.
Cicone F; Clerico A; Minniti G; Paiano M; Carideo L; Scaringi C; Langen KJ; Scopinaro F
World Neurosurg; 2016 Sep; 93():490.e7-490.e11. PubMed ID: 27354292
[TBL] [Abstract][Full Text] [Related]
11. Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence.
Calabria F; Cascini GL
Hell J Nucl Med; 2015; 18(2):152-6. PubMed ID: 26187216
[TBL] [Abstract][Full Text] [Related]
12. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
Calabria FF; Calabria E; Gangemi V; Cascini GL
Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
